Advertisement

U.S. Markets open in 56 mins

S&P Futures
5,888.00
-8.50(-0.14%)
Dow Futures
43,457.00
-111.00(-0.25%)
Nasdaq Futures
20,485.75
-8.00(-0.04%)
Russell 2000 Futures
2,315.80
+2.20(+0.10%)
Crude Oil
67.35
+0.33(+0.49%)
Gold
2,600.20
+30.10(+1.17%)

ENDRA Life Sciences Inc. (NDRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

4.5400

-0.7600

(-14.34%)

At close: 04:00PM EST

4.5400

0.00

(0.00%)

Pre-Market:

08:29AM EST

Trade prices are not sourced from all markets

All

Business Wire
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
ANN ARBOR, Mich., November 15, 2024--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months ended September 30, 2024 and provided a business update.
Business Wire
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
ANN ARBOR, Mich., November 12, 2024--ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced the acceptance of a poster titled "Noninvasive assessment of steatotic liver disease in individuals with class 2 and class 3 obesity" for presentation at The Liver Meeting 2024, hosted by the American Association for the Study of Liver Disease (AASLD), taking place November 15-19 in San Diego.